Upsher Smith Labs Drug Patent Portfolio
Upsher Smith Labs owns 3 orange book drugs protected by 12 US patents Given below is the list of Upsher Smith Labs's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8785426 | Testosterone gel compositions and related methods | 11 Feb, 2034 | Active |
| US9295675 | Testosterone gel compositions and related methods | 11 Feb, 2034 | Active |
| US9622340 | Flexible circuit board and method for manufacturing same | 11 Feb, 2034 | Active |
| US9662340 | Testosterone gel compositions and related methods | 11 Feb, 2034 | Active |
| US10363224 | Extended-release topiramate capsules | 19 Mar, 2033 | Active |
| US8652527 | Extended-release topiramate capsules | 19 Mar, 2033 | Active |
| US8889190 | Extended-release topiramate capsules | 19 Mar, 2033 | Active |
| US9101545 | Extended-release topiramate capsules | 19 Mar, 2033 | Active |
| US9555005 | Extended-release topiramate capsules | 19 Mar, 2033 | Active |
| US6440392 | Nasal calcitonin formulations | 02 Feb, 2021 | Expired |
| USRE40812 | Nasal calcitonin formulation | 02 Feb, 2021 | Expired |
| USRE43580 | Nasal calcitonin formulations | 02 Feb, 2021 | Expired |
Latest Legal Activities on Upsher Smith Labs's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Upsher Smith Labs.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 12 Jun, 2024 | US9662340 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Feb, 2023 | US9101545 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Jan, 2023 | US10363224 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 May, 2022 | US8889190 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 Aug, 2021 | US8785426 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Aug, 2021 | US8652527 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Sep, 2020 | US9622340 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 31 Jul, 2020 | US9555005 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 04 Jun, 2020 | US9662340 |
|
Recordation of Patent Grant Mailed
Critical
| 30 Jul, 2019 | US10363224 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 30 Jul, 2019 | US10363224 |
|
Email Notification
Critical
| 11 Jul, 2019 | US10363224 |
|
Issue Notification Mailed
Critical
| 10 Jul, 2019 | US10363224 |
| Dispatch to FDC | 26 Jun, 2019 | US10363224 |
|
Issue Fee Payment Received
Critical
| 07 Jun, 2019 | US10363224 |
Upsher Smith Labs's Family Patents
Upsher Smith Labs Drug List
Given below is the complete list of Upsher Smith Labs's drugs and the patents protecting them.
1. Fortical
Fortical is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6440392 | Nasal calcitonin formulations |
02 Feb, 2021
(3 years ago)
| Expired |
| USRE40812 | Nasal calcitonin formulation |
02 Feb, 2021
(3 years ago)
| Expired |
| USRE43580 | Nasal calcitonin formulations |
02 Feb, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fortical's drug page
2. Qudexy Xr
Qudexy Xr is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10363224 | Extended-release topiramate capsules |
19 Mar, 2033
(8 years from now)
| Active |
| US8652527 | Extended-release topiramate capsules |
19 Mar, 2033
(8 years from now)
| Active |
| US8889190 | Extended-release topiramate capsules |
19 Mar, 2033
(8 years from now)
| Active |
| US9101545 | Extended-release topiramate capsules |
19 Mar, 2033
(8 years from now)
| Active |
| US9555005 | Extended-release topiramate capsules |
19 Mar, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qudexy Xr's drug page
3. Vogelxo
Vogelxo is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8785426 | Testosterone gel compositions and related methods |
11 Feb, 2034
(9 years from now)
| Active |
| US9295675 | Testosterone gel compositions and related methods |
11 Feb, 2034
(9 years from now)
| Active |
| US9622340 | Flexible circuit board and method for manufacturing same |
11 Feb, 2034
(9 years from now)
| Active |
| US9662340 | Testosterone gel compositions and related methods |
11 Feb, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vogelxo's drug page